Rwanda vs SEAR: Estimated antiretroviral therapy coverage among people living with HIV
Rwanda
94.0%
in 2025
SEAR
22.0%
in 2025
Rwanda rank
11th
SEAR rank
12th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Rwanda
- SEAR
How they compare
Rwanda currently reports 94.0% against 22.0% in SEAR, a difference of 72.0%.
That makes Rwanda's figure about 4.3 times SEAR's.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was SEAR ahead.
Rwanda ranks 11th and SEAR ranks 12th of 143 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.1% | 2.2% | 7.9% | Rwanda |
| 2010s | 59.9% | 12.3% | 47.6% | Rwanda |
| 2020s | 89.8% | 20.3% | 69.5% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Rwanda or SEAR?
- Rwanda, at 94.0% against 22.0% in SEAR as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Rwanda and SEAR?
- 72.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and SEAR?
- 26 years are reported by both, from 2000 to 2025.
- How do Rwanda and SEAR rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Rwanda ranks 11th and SEAR ranks 12th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.